# Genenta Science S.p.A.: Form 20-F for the period ended Dec 31, 2024

- Company: [Genenta Science S.p.A.](/companies/gnta.md) (CIK 1838716)
- Form: 20-F
- Filed: 2025-03-28
- Accepted by EDGAR: Mar 28, 2025, 16:25 ET
- Period: 2024-12-31
- Accession: 0001641172-25-001207
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1838716/000164117225001207/form20-f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1838716/000164117225001207/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 12 months, 2024-01-01 to 2024-12-31 | EUR 4.8m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2024-01-01 to 2024-12-31 | −EUR 9.8m | us-gaap:OperatingIncomeLoss |
| Net income | 12 months, 2024-01-01 to 2024-12-31 | −EUR 8.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2024-01-01 to 2024-12-31 | −EUR 0.49 | us-gaap:EarningsPerShareDiluted |
| Diluted shares (weighted) | 12 months, 2024-01-01 to 2024-12-31 | 18,273,490 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2024-01-01 to 2024-12-31 | −EUR 6.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2024-01-01 to 2024-12-31 | EUR 4.5k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2024-12-31 | EUR 4.0k | us-gaap:Cash |
| Current assets | at 2024-12-31 | EUR 14.5m | us-gaap:AssetsCurrent |
| Total assets | at 2024-12-31 | EUR 14.8m | us-gaap:Assets |
| Current liabilities | at 2024-12-31 | EUR 2.1m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2024-12-31 | EUR 12.5m | us-gaap:StockholdersEquity |
| Shares outstanding | at 2024-12-31 | 18,289,866 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1838716/000164117225001207/form20-f.htm

Filed Mar 28, 2025.
Source: SEC EDGAR, the filing index for accession 0001641172-25-001207. Last ingested by Listed: Nov 2, 2026, 06:07 ET. No prices; not investment advice.